Insider Transactions in Q3 2023 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2023
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
11,000
-19.98%
|
$187,000
$17.06 P/Share
|
|
Sep 05
2023
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
23,853
-30.22%
|
$405,501
$17.81 P/Share
|
|
Aug 11
2023
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
48,064
-4.99%
|
$865,152
$18.91 P/Share
|
|
Aug 11
2023
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
122,143
+11.26%
|
-
|
|
Aug 11
2023
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
8,901
-5.21%
|
$160,218
$18.91 P/Share
|
|
Aug 11
2023
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+11.68%
|
-
|
|
Aug 11
2023
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
9,592
-10.84%
|
$172,656
$18.91 P/Share
|
|
Aug 11
2023
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
19,346
+17.94%
|
-
|
|
Aug 11
2023
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,215
-10.94%
|
$201,870
$18.91 P/Share
|
|
Aug 11
2023
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+18.08%
|
-
|
|
Aug 03
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
26,279
-3.03%
|
$578,138
$22.57 P/Share
|
|
Jul 03
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
26,279
-2.94%
|
$630,696
$24.94 P/Share
|
|
Jul 03
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
1,701
-2.08%
|
$42,525
$25.04 P/Share
|